Keep up with mProve. Here you can browse through the conferences we attend, the talks we give, and other events where you can find us.
- This event has passed.
June 18 - June 22
Denis Curtin, CSO, mProve Health, will be co-presenting with Takeda on “The Development and Launch of a Unique Retention Focused Patient Centric Online Community for the TOMMORROW Study.”
To improve the experience of Alzheimer’s Disease patients in their clinical trial, the TOMMORROW study team created an innovative, technology-focused online community. Online gathering places can easily incorporate fundamental features of community such as membership, a sense of influence, and shared emotional connection. However, some of these features can be difficult to incorporate into a necessarily confidential and highly controlled clinical trial. The TOMMORROW study community addresses these challenges in several innovative ways. It safely incorporates the benefits of community building into a clinical trial, thus supporting patient engagement and positive outcomes.
For more details, visit http://www.diaglobal.org/en/flagship/dia-2017